Fundraising boosts Implant Sciences' breast brachytherapy
This article was originally published in Clinica
Executive Summary
Implant Sciences says it will use some of the $2m it has just raised through a convertible preferred stock placement to develop its brachytherapy technology for treating breast cancer. The cash, provided by existing investor Laurus Funds, will also be used to commercialise the Wakefield, Massachusetts firm's hand-held system for detecting explosives.